Incidence, Prevalence, and Lifetime Risk Estimates of Heart Failure

Key Points

• Approximately 6.7 million Americans over 20 years of age have HF, and the prevalence is expected to rise to 8.7 million Americans in 2030, 10.3 million in 2040, and 11.4 million Americans by 2050.   
• The lifetime risk of HF has increased to 24%; approximately 1 in 4 persons will develop HF in their lifetime.   
• The prevalence of HF among US adults is approximately 1.9% to 2.8 % for the overall population and is higher among older patients. The prevalence is expected to increase to 8.5% among 65 to 70-year-olds.
• The trend for heart failure with preserved ejection fraction (HFpEF) across populations is increasing with significant differences by race and ethnicity. Women experience a higher lifetime risk of HFpEF.   
• Approximately 33% of the US adult population without known symptomatic HF is at-risk for HF (Stage A) and 24-34% have pre-HF (Stage B). The risk of developing HF in individuals with obesity and hypertension continues to increase.
• The incidence and prevalence of HF are higher among Black individuals compared to other racial and ethnic groups. The prevalence of HF has increased among Black and Hispanic/Latino individuals over time.